Douglas L Jennings (Douglas J Jennings, Douglas Jennings)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 21

Top Topics

Left Ventricular Assist Device

Percutaneous Coronary Intervention

Antiplatelet Therapy

Top Venues

Pharmacotherapy

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Heart failure reviews

Clinical transplantation

This page only lists publications with an associated author ORCID identifier.

Publications

Xinyi Huang, David M Salerno, Danielle Bley Kovac, Jenna Scheffert, Jessica Hedvat, Bayleigh Carver, Jason Y Choe, Tara Shertel, Melana Yuzelpolskaya, Paolo C Colombo, Douglas L Jennings
Contemporary Immunosuppression Management and 1-Year Outcomes in Dual Organ Heart Transplantation. Clinical transplantation 38 (8) (2024)
Douglas L Jennings, William L Baker
Impact of the United Network for Organ Sharing policy change on induction immunosuppression practice patterns and outcomes in adult heart transplant recipients. Pharmacotherapy 43 (2) (2023)
Douglas L Jennings, William L Baker
Impact of the United Network for Organ Sharing Policy Change on Induction Immunosuppression Practice Patterns and Outcomes in Adult Heart Transplant Recipients. Pharmacotherapy (2023)
Douglas L Jennings, William L Baker
Impact of the United Network for Organ Sharing policy change on induction immunosuppression practice patterns and outcomes in adult heart transplant recipients. Pharmacotherapy 43 (2) (2023)
Douglas L Jennings, William L Baker
Impact of the United Network for Organ Sharing policy change on induction immunosuppression practice patterns and outcomes in adult heart transplant recipients. Pharmacotherapy 43 (2) (2023)
Douglas L Jennings, William L Baker
Impact of the United Network for Organ Sharing policy change on induction immunosuppression practice patterns and outcomes in adult heart transplant recipients. Pharmacotherapy 43 (2) (2023)
Douglas L Jennings, William L Baker
Impact of the United Network for Organ Sharing policy change on induction immunosuppression practice patterns and outcomes in adult heart transplant recipients. Pharmacotherapy (2023)
Jessica Hedvat, David M Salerno, Danielle Bley Kovac, Jenna L Scheffert, Heather Corbo, Justin K Chen, Jason Y Choe, Douglas L Jennings, Anastasia Anamisis, Esther C Liu, Jennifer H Lee, Tara Shertel, Nicholas W Lange
Nitazoxanide treatment for norovirus infection in solid organ transplant recipients. Clinical transplantation 36 (3) (2022)
Nicholas W Lange, David M Salerno, Douglas L Jennings, Jason Y Choe, Jessica Hedvat, Danielle Bley Kovac, Jenna Scheffert, Tara Shertel, Lloyd E Ratner, Robert S Brown, Marcus R Pereira
Nirmatrelvir/ritonavir use: Managing clinically significant drug-drug interactions with transplant immunosuppressants. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 22 (7) (2022)
David M Salerno, Douglas L Jennings, Nicholas W Lange, Danielle Bley Kovac, Tara Shertel, Justin K Chen, Jessica Hedvat, Jenna Scheffert, Robert S Brown, Marcus R Pereira
Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID-19 in solid organ transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 22 (8) (2022)
Jessica Hedvat, Nicholas W Lange, David M Salerno, Ersilia M DeFilippis, Danielle Bley Kovac, Heather Corbo, Justin K Chen, Jason Y Choe, Jennifer H Lee, Anastasia Anamisis, Douglas L Jennings, Giovanna Codispodo, Tara Shertel, Robert S Brown, Marcus R Pereira
COVID-19 therapeutics and outcomes among solid organ transplant recipients during the Omicron BA.1 era. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 22 (11) (2022)
Douglas L Jennings, Lina Sultan, Jennifer Mingov, Jason Choe, Farhana Latif, Susan Restaino, Kevin Clerkin, Marlena V Habal, Paolo C Colombo, Melana Yuzefpulskaya, Gabriel Sayer, Nir Uriel, William L Baker
PCSK9 inhibitors safely and effectively lower LDL after heart transplantation: a systematic review and meta-analysis. Heart failure reviews (2022)
Danielle Bley Kovac, Jason Choe, Esther Liu, Jenna Scheffert, Jessica Hedvat, Anastasia Anamisis, David Salerno, Nicholas Lange, Douglas L Jennings
Immunosuppression considerations in simultaneous organ transplant. Pharmacotherapy 41 (1) (2021)
Douglas L Jennings, Naga Vaishnavi Gadela, Abhishek Jaiswal, Amanda Touch, William L Baker
Pre-transplant amiodarone use does not affect long-term heart transplant survival. Pharmacotherapy (2021)
Ian B Hollis, Christina Teeter Doligalski, Douglas L Jennings
Pharmacotherapy for durable left ventricular assist devices. Pharmacotherapy 41 (1) (2021)
Douglas L Jennings, Lauren K Truby, Audrey J Littlefield, Alana M Ciolek, Dylan Marshall, Rashmi Jain, Veli K Topkara
Impact of heart failure drug therapy on rates of gastrointestinal bleeding in LVAD recipients: An INTERMACS analysis. The International journal of artificial organs 44 (12) (2021)
Craig J Beavers, Robert J DiDomenico, Steven P Dunn, Jenna Cox, Long To, Phillip Weeks, Toby C Trujillo, Douglas L Jennings
Optimizing anticoagulation for patients receiving Impella support. Pharmacotherapy 41 (11) (2021)
Audrey J Littlefield, Gregory Jones, Alana M Ciolek, Melana Yuzefpolskaya, Douglas L Jennings
A reappraisal of the pharmacologic management of gastrointestinal bleeding in patients with continuous flow left ventricular assist devices. Heart failure reviews 26 (2) (2020)
Douglas L Jennings, Bruno Bohn, Amelia Zuver, Duygu Onat, Maureen Gaine, Eugene Royzman, Jonathan Hupf, Danielle Brunjes, Farhana Latif, Susan Restaino, Arthur Reshad Garan, Veli K Topkara, Hiroo Takayama, Koji Takeda, Yoshifumi Naka, Maryjane Farr, Renu Nandakumar, Anne-Catrin Uhlemann, Paolo C Colombo, Ryan T Demmer, Melana Yuzefpolskaya
Gut microbial diversity, inflammation, and oxidative stress are associated with tacrolimus dosing requirements early after heart transplantation. PloS one 15 (5) (2020)
Shudhanshu Alishetti, Maryjane A Farr, Douglas L Jennings, Geo Serban, Nir Uriel, Gabriel T Sayer, Elena-Rodica M Vasilescu, Susan Restaino, Anita S Chong, Marlena V Habal
Desensitizing highly sensitized heart transplant candidates with the combination of belatacept and proteasome inhibition. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20 (12) (2020)
Alana M Ciolek, Karlene Ma, Arthur Reshad Garan, Andrew B Eisenberger, Douglas L Jennings
Use of cangrelor during venoarterial extracorporeal membrane oxygenation following percutaneous coronary intervention. Artificial organs 44 (3) (2019)